date:Oct 08, 2012
e paper, are inadequate.
Scientifically unsound
EFSA said: The numerous issues relating to the design and methodology of the study, as described in the paper, mean that no conclusions can be made about the occurrence of tumours in the rats tested.
The watchdog has invited Sralini and his colleagues to share more key information about the study.
Per Bergman, who led EFSAs research, said: Some may be surprised that EFSAs statement focuses on the methodology of this study rather than its outcom